Addressing epistasis in the design of protein function

Rosalie Lipsh-Sokolik*, Sarel J. Fleishman*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Mutations in protein active sites can dramatically improve function. The active site, however, is densely packed and extremely sensitive to mutations. Therefore, some mutations may only be tolerated in combination with others in a phenomenon known as epistasis. Epistasis reduces the likelihood of obtaining improved functional variants and dramatically slows natural and lab evolutionary processes. Research has shed light on the molecular origins of epistasis and its role in shaping evolutionary trajectories and outcomes. In addition, sequence- and AI-based strategies that infer epistatic relationships from mutational patterns in natural or experimental evolution data have been used to design functional protein variants. In recent years, combinations of such approaches and atomistic design calculations have successfully predicted highly functional combinatorial mutations in active sites. These were used to design thousands of functional activesite variants, demonstrating that, while our understanding of epistasis remains incomplete, some of the determinants that are critical for accurate design are now sufficiently understood. We conclude that the space of active-site variants that has been explored by evolution may be expanded dramatically to enhance natural activities or discover new ones. Furthermore, design opens the way to systematically exploring sequence and structure space and mutational impacts on function, deepening our understanding and control over protein activity.

Original languageEnglish
Article numbere2314999121
JournalProceedings of the National Academy of Sciences
Volume121
Issue number34
DOIs
Publication statusPublished - 20 Aug 2024

Bibliographical note

We thank Ziv Avizemer for providing structure models that were used to generate Fig. 3A. R.L.-S. was supported by a fellowship from the Arianne de Rothschild Women Doctoral Program. Work in the Fleishman lab was funded by the Volkswagen Foundation grant 9474, the Israel Science Foundation grant 1844, the European Research Council through a Consolidator Award grant 815379, the Dr. Barry Sherman Institute for Medicinal Chemistry, and a donation in memory of Sam Switzer.

Publisher Copyright:
Copyright © 2024 the Author(s). Published by PNAS.

All Science Journal Classification (ASJC) codes

  • General

Fingerprint

Dive into the research topics of 'Addressing epistasis in the design of protein function'. Together they form a unique fingerprint.

Cite this